ARTICLE | Clinical News
OMS302: Phase IIb started
August 2, 2010 7:00 AM UTC
Omeros began a double-blind Phase IIb trial in 200 patients undergoing cataract surgery to compare OMS302, the pupil-dilating component of OMS302, the anti-inflammatory component of OMS302 or placebo....